SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-019536
Filing Date
2024-06-07
Accepted
2024-06-07 07:30:13
Documents
16
Period of Report
2024-06-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240606_8k.htm   iXBRL 8-K 29847
2 EXHIBIT 99.1 ex_684481.htm EX-99.1 10291
7 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-24-019536.txt   182334

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20240604.xsd EX-101.SCH 3400
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240604_def.xml EX-101.DEF 11420
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240604_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240604_pre.xml EX-101.PRE 11580
19 EXTRACTED XBRL INSTANCE DOCUMENT nby20240606_8k_htm.xml XML 2849
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 241027370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)